These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). Takimoto T; Ogura H; Sato H; Umeda R; Hatano M J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties. Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells. Takimoto T; Umeda R; Ogura H; Hatano M Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983 [TBL] [Abstract][Full Text] [Related]
10. Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV. Takimoto T; Sato H; Ogura H; Miyazaki T Auris Nasus Larynx; 1987; 14(2):87-92. PubMed ID: 2835030 [TBL] [Abstract][Full Text] [Related]
11. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus. Takimoto T; Sato H; Ogura H; Miyazaki T Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome. Sato H; Takimoto T; Hatano M; Pagano JS; Raab-Traub N J Gen Virol; 1989 Mar; 70 ( Pt 3)():717-27. PubMed ID: 2543756 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells. Takimoto T; Furukawa M; Hatano M; Umeda R Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):166-9. PubMed ID: 6324641 [TBL] [Abstract][Full Text] [Related]
14. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor. Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992 [TBL] [Abstract][Full Text] [Related]
15. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma. Takimoto T; Umeda R Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line. Yoshizaki T; Takimoto T; Takeshita H; Tanaka S; Furukawa M; Seiki M; Sato H Laryngoscope; 1994 Jan; 104(1 Pt 1):91-4. PubMed ID: 8295464 [TBL] [Abstract][Full Text] [Related]
17. [Recover of transforming Epstein-Barr virus (EBV) from Raji cells superinfected with NPC-KT EBV]. Takimoto T; Iwawaki J; Ishikawa S; Tanaka S; Masuda K Nihon Jibiinkoka Gakkai Kaiho; 1987 Nov; 90(11):1767-71. PubMed ID: 2833593 [No Abstract] [Full Text] [Related]
18. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877 [TBL] [Abstract][Full Text] [Related]